Fosfomycin
ME Falagas, EK Vouloumanou… - Clinical microbiology …, 2016 - Am Soc Microbiol
The treatment of bacterial infections suffers from two major problems: spread of multidrug-
resistant (MDR) or extensively drug-resistant (XDR) pathogens and lack of development of …
resistant (MDR) or extensively drug-resistant (XDR) pathogens and lack of development of …
[HTML][HTML] Fosfomycin: pharmacological, clinical and future perspectives
AC Dijkmans, NV Ortiz Zacarías, J Burggraaf… - Antibiotics, 2017 - mdpi.com
Fosfomycin is a bactericidal, low-molecular weight, broad-spectrum antibiotic, with putative
activity against several bacteria, including multidrug-resistant Gram-negative bacteria, by …
activity against several bacteria, including multidrug-resistant Gram-negative bacteria, by …
[PDF][PDF] 2013 年中国CHINET 细菌耐药性监测
胡付品, 朱德妹, 汪复, 蒋晓飞, 孙自镛, 陈中举… - 2014 - chinets.com
目的了解国内主要地区临床分离菌对常用抗菌药物的敏感性和耐药性. 方法国内主要地区16
所教学医院(14 所综合性医院, 2 所儿童医院) 临床分离菌采用纸片扩散法或自动化仪器法按统一 …
所教学医院(14 所综合性医院, 2 所儿童医院) 临床分离菌采用纸片扩散法或自动化仪器法按统一 …
Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms
EA Neuner, J Sekeres, GS Hall… - Antimicrobial agents and …, 2012 - Am Soc Microbiol
Fosfomycin has shown promising in vitro activity against multidrug-resistant (MDR) urinary
pathogens; however, clinical data are lacking. We conducted a retrospective chart review to …
pathogens; however, clinical data are lacking. We conducted a retrospective chart review to …
[HTML][HTML] Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance
A Castañeda-García, J Blázquez, A Rodríguez-Rojas - Antibiotics, 2013 - mdpi.com
Bacterial infections caused by antibiotic-resistant isolates have become a major health
problem in recent years, since they are very difficult to treat, leading to an increase in …
problem in recent years, since they are very difficult to treat, leading to an increase in …
Fosfomycin: resurgence of an old companion
S Sastry, Y Doi - Journal of Infection and Chemotherapy, 2016 - Elsevier
Fosfomycin was discovered over four decades ago, yet has drawn renewed interest as an
agent active against a range of multidrug-resistant (MDR) and extensively drug-resistant …
agent active against a range of multidrug-resistant (MDR) and extensively drug-resistant …
Global prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: A systematic review and meta-analysis
Introduction Acinetobacter baumannii antimicrobial resistance is a public health concern in
developing and developed countries, especially in the hospital setting. Understanding the …
developing and developed countries, especially in the hospital setting. Understanding the …
Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature
KZ Vardakas, NJ Legakis, N Triarides… - International journal of …, 2016 - Elsevier
The aim of this review was to evaluate the susceptibility of contemporary Gram-positive and
Gram-negative bacteria to fosfomycin. PubMed and Scopus databases were systematically …
Gram-negative bacteria to fosfomycin. PubMed and Scopus databases were systematically …
Combination therapy for carbapenem-resistant Gram-negative bacteria
AP Zavascki, JB Bulitta… - Expert review of anti …, 2013 - Taylor & Francis
The emergence of resistant to carbapenems Gram-negative bacteria (CR GNB) has severely
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to …
Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany
M Kaase, F Szabados, A Anders… - Journal of Clinical …, 2014 - Am Soc Microbiol
Due to the increase in multidrug-resistant Enterobacteriaceae, the interest in older
antimicrobial agents, like fosfomycin, has increased. In this study, we used agar dilution for …
antimicrobial agents, like fosfomycin, has increased. In this study, we used agar dilution for …